PubMed Health⌕ Search

Biomedical subjects

H Makker

Publications and source records attributed to H Makker.

7 recordsLinked to original sources
PubMed2002

Some factors affecting cerebral tissue saturation during obstructive sleep apnoea.

Measurement of cerebral tissue saturation during obstructive sleep apnoea (OSA) may provide additional information to conventional peripheral oxygen saturation. Thirteen subjects with OSA (mean apnoea/hypopnoea index 65.7+/-27.9) were monitored using full polysomnography and monitoring of near-infrared cerebral tissue oxygenation index (TOI). One-thousand and thirty-six apnoeas and hypopnoeas were analysed, in terms of duration, sleep stage, arterial oxygen saturation (Sa,O2) dip, minimum Sa,O2, TOI dip and minimum TOI. Cerebral TOI is a measure of cerebral tissue saturation of haemoglobin with oxygen, calculated using near-infrared spatially resolved spectroscopy, which has been shown to have a high specificity for intracranial changes. Decreases in cerebral oxygenation were observed during apnoeas and hypopnoeas. Baseline TOI ranged from 50.1-73.0% and mean apnoea/hypopnoea related TOI dips ranged from 1.43-6.85%. Mean Sa,O2 dips varied from 3.8-21.7%. In regression analysis, factors significantly predicting the magnitude of the TOI dip were Sa,O2 dip, minimum Sa,O2, apnoea duration and rapid eye movement sleep stage. The effect of apnoea duration and sleep stage remained significant after Sa,O2 was included in the regression equation. Near-infrared spectroscopy provides a noninvasive technique for monitoring cerebral tissue saturation during obstructive sleep apnoea.

Adult↗
PubMed1999

Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers.

OBJECTIVES: To compare the systemic bioavailability (assessed by cortisol suppression) of high-dose budesonide when given by four inhaler devices and orally. Also studied are the relative systemic potencies of three inhaled steroids (budesonide, fluticasone propionate, and beclomethasone dipropionate) when given by metered-dose inhaler (MDI) with a large volume spacer. DESIGN: Double-blind, crossover, placebo-controlled trial. PARTICIPANTS: Sixteen healthy, steroid-naive adult volunteers. METHODS: On separate occasions, each subjects took 4 mg of budesonide through the following devices: MDI alone, MDI with 750-mL. spacer, dry-powder inhaler and nebulizer; 4 mg of budesonide was also taken orally to assess the effects of GI absorption. For the drug comparison, each subject took 4 mg of budesonide, fluticasone, and beclomethasone, and 2 mg of budesonide and fluticasone by MDI and spacer. RESULTS: Greatest percent suppression (95% confidence interval) of 9:00 AM cortisol with budesonide was observed with MDI alone (73% [57 to 90]) and turbohaler (72% [58 to 86]) compared with MDI spacer (42% [22 to 64]) and oral administration (14% [+6- to -34]). Nebulized budesonide produced an insignificant rise in 9:00 AM cortisol level. The most suppressive drug (given by MDI spacer) was fluticasone at 4 mg (86% [82 to 91]) and at 2 mg (72% [59 to 85]). The least suppressive drug was budesonide at 4 mg (43% [22 to 64]) and at 2 mg (25% [3 to 47]). The effects of 4 mg of beclomethasone were intermediate (66% [49 to 82%]). CONCLUSIONS: The choice of delivery device for administration of budesonide can lead to important differences in systemic bioavailability. Fluticasone has greater systemic potency than budesonide or beclomethasone when given at microgram equivalent dosage. The systemic potency ratio of fluticasone propionate to budesonide in normal human volunteers in the present study is similar to the therapeutic potency ratio of the drug in asthmatic patients (approximately 2:1).

Administration, Oral↗
PubMed1995

Effect of silicone sound speed and intraocular lens thickness on pseudophakic axial length corrections.

We compared the sound speeds of SLM-1/UV (990 M/sec at 35 degrees Celsius [degrees C]), SLM-2/UV (1090 M/sec at 35 degrees C), and Perspex CQ poly(methyl methacrylate)(2658 M/sec at 35 degrees C). Methods are presented to determine the correction of axial length (CAL) factors for axial length measurements made on pseudophakes with AMO PhacoFlex Si-18, Si-26 (SLM-1/UV), and AMO PhacoFlex II SI-20 or SI-30 (SLM-2/UV) silicone intraocular lenses (IOLs). A CAL is required to avoid potential errors with secondary IOL power predictions; CALs, which are strongly dependent on the material sound speed and less so on lens thickness, ranged from -0.65 mm to -1.20 mm for SLM-1/UV silicone IOLs and from -0.35 mm to -0.55 mm for SLM-2/UV silicone IOLs. The sound speeds of IOL materials varied insignificantly between ambient room temperature (23 degrees C) and intraocular temperature (35 degrees C).

Artifacts↗
PubMedDate not supplied

Accelerated ultraviolet aging of intraocular lens optic materials: a 50 year simulation.

PURPOSE: To introduce an updated accelerated photoaging model for application to intraocular lens (IOL) materials and to apply this model to determine the photostability of AMO PhacoFlex model SI-18NGB and PhacoFlex II model SI-20NGB silicone IOL materials over a simulated 50 years of exposure. SETTING: Research laboratory, AMO Surgical Products, Irvine, California, USA. METHODS: Previous photoaging models and aging parameters, including intraocular exposure intensity, daily exposure duration, and acceleration exponent were critically reviewed and analyzed, and an updated model was introduced. The test specimens were continuously irradiated with ultraviolet (UV) light in a Suntest UV chamber at an intensity of 8 mw/cm2 for 86 days to simulate 50 years of in vivo exposure. The silicone lenses were evaluated for focal length, resolution, and surface integrity, while regular slabs were tested for tensile strength, elongation, hardness, contact angle, and percentage light transmission. The UV-absorption capacity was monitored using ultrathin slabs (0.127 mm). Six replicate samples were used for each determination, and a two-sided t-test with significance set at P < .05 was used to evaluate the difference before and after aging. RESULTS: No significant difference in optical, physical, and surface properties of the lenses and lens materials was found. No change in UV-absorption capacity was observed after a simulated 50 years of accelerated photoaging. CONCLUSION: The AMO PhacoFlex SI-18NGB and PhacoFlex II SI-30NGB silicone lens materials resisted UV light degradation over 50 years of simulated exposure.

Lenses, Intraocular↗